Ahmed Ba-Ssalamah MD, Presenter: Speaker, Bayer AG Speaker, Siemens AG

Aliya Qayyum MBBS, Presenter: Spouse, Employee, Imorgon Medical

Richard Michael Gore MD, Presenter: Nothing to Disclose

1) Describe MRI ; MRCP techniques for evaluating biliary disease. 2) List applications in malignant biliary disease. 3) List applications in benign conditions of the biliary tract.    

This workshop is designed to review the broad spectrum of morphologic and functional features encountered in patients with cholestatic liver diseases involving the intrahepatic and extrahepatic bile ducts and adjacent liver parenchyma, in correlation with the histopathologic hallmark of this group of diseases the so-called “vanishing duct sign. We will start by explaining the role  of various different imaging modalities including invasive endoscopic retrograde cholangiopancreatography (ERCP) and non-invasive conventional T2 weighted magnetic resonance cholangiography (MRCP) as well as gadoxetic acid-enhanced T1 MRCP and diffusion weighted images to expedite the evaluation of patients with known or suspected cholestatic liver diseases.  Next, we will discuss the broad spectrum of biliary disorders that define cholestatic liver diseases including: primary sclerosing cholangitis (PSC), primary biliary cirrhosis (PBC), ischemic cholangiopathy, chronic rejection following liver transplant, drug-induced liver injury (DILI), infectious secondary cholangitis, cystic fibrosis (CF), etc.  

Ba-Ssalamah, A, Qayyum, A, Gore, R, Modern Non-invasive Imaging of Cholestatic Liver Diseases (How-to Workshop).  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14000795.html